Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

Pharmalot By Ed Silverman

Advocacy groups outraged after a PBM offers a $500 gift card to persuade patients to switch drugs

“They’re paying off the patients. It’s the first I’ve ever seen this done and it’s egregious, just awful,” said Mark Lebwohl of Mount Sinai.

Read The Story

Biotech By Elizabeth Cooney

How nanotechnology helps mRNA Covid-19 vaccines work

Pharma By Madlen Davies, Ivan Ruiz, Jill Langlois, and Rosa Furneaux — The Bureau of Investigative Journalism

‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries

A STAT Investigation By Charles Piller

Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients

Pharmalot By Ed Silverman

A drug maker sues a medical journal, its editor, and several authors for libel

All Coverage

Pharmalot By Ed Silverman

Pharmalittle: J&J rivals rebuff bid to jointly study Covid-19 vaccine risks; will next-gen Covid shots be better or worse?

Biotech By Anissa Gardizy — Boston Globe

Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot

Opinions+ By Pierre Bourdage

Pharmalittle: Lilly arthritis drug failed main goal in Covid-19 study; Serum Institute asks India for a big grant to make Covid shots

Pharmalot By Ed Silverman

Brazilian judge temporarily suspends pharmaceutical patent extensions amid push to lower drug costs

Pharmalot By Ed Silverman

Pharmalittle: EMA finds link between AstraZeneca shot and rare blood clots; life science private financing is at record levels

Pharmalot By Ed Silverman

Judge rules Purdue must answer questions about documents showing any link between OxyContin, birth defects

Pharmalot By Ed Silverman

Advocacy groups outraged after a PBM offers a $500 gift card to persuade patients to switch drugs

How nanotechnology helps mRNA Covid-19 vaccines work

‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries

Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients

A drug maker sues a medical journal, its editor, and several authors for libel

All Coverage

Pfizer shareholders are urged to reject political spending that contradicts ‘company values’

Pharmalittle: Biden aides met with U.S. health companies about supply chains; J&J Covid-19 shot notched $100m in sales

Pharmalittle: J&J denies design of its Covid-19 shot may explain blood clots; second trial against opioid makers begins

Up and down the ladder: The latest comings and goings

Pharmalittle: J&J rivals rebuff bid to jointly study Covid-19 vaccine risks; will next-gen Covid shots be better or worse?

Thermo Fisher buys contract-research company PPD for $17.4 billion

WTO head urges movement on controversial Covid-19 vaccine proposal, but objections remain

Pharmalittle: Pause for J&J Covid-19 shot to continue at least a week; Biden expands candidate list for FDA commish

WHO warns the world is still failing to develop desperately needed antibiotics

FDA is urged to move faster to list medicines withdrawn over safety concerns

Pharmalittle: Pfizer to boost Covid-19 vaccine production for the U.S.; J&J faces new test with Covid-shot pause

A U.S. appeals court upholds the FTC view of controversial pay-to-delay settlements

Pharmalittle: U.S. urges states to pause J&J Covid-19 shots; PhRMA’s new message says ‘Don’t take us for granted’

Europe tries to lower drug prices with small doses of transparency

Federal agency says pharma should pay higher Medicaid rebates if certain trials aren’t finished on time

Pharmalittle: Regeneron antibody reduced Covid-19 infection risk; variant first seen in South Africa can somewhat ‘break through’ Pfizer shot

Three steps toward creating a functioning U.S. biosimilars market

Clinical study reports hold more details about the side effects of cancer drugs

Up and down the ladder: The latest comings and goings

Pharmalittle: Lilly arthritis drug failed main goal in Covid-19 study; Serum Institute asks India for a big grant to make Covid shots

Brazilian judge temporarily suspends pharmaceutical patent extensions amid push to lower drug costs

Pharmalittle: EMA finds link between AstraZeneca shot and rare blood clots; life science private financing is at record levels

Judge rules Purdue must answer questions about documents showing any link between OxyContin, birth defects

Merck reaches deal with Austrian antitrust regulators over ‘predatory’ pricing for a cancer drug